HRP20150260T1 - Uporaba biotina za lijeäśenje multiple skleroze - Google Patents
Uporaba biotina za lijeäśenje multiple skleroze Download PDFInfo
- Publication number
- HRP20150260T1 HRP20150260T1 HRP20150260TT HRP20150260T HRP20150260T1 HR P20150260 T1 HRP20150260 T1 HR P20150260T1 HR P20150260T T HRP20150260T T HR P20150260TT HR P20150260 T HRP20150260 T HR P20150260T HR P20150260 T1 HRP20150260 T1 HR P20150260T1
- Authority
- HR
- Croatia
- Prior art keywords
- biotin
- multiple sclerosis
- treatment
- indicated
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1257254A FR2993780B1 (fr) | 2012-07-26 | 2012-07-26 | Methode de traitement de la sclerose en plaque |
| US13/644,615 US8835487B2 (en) | 2012-07-26 | 2012-10-04 | Method of treating multiple sclerosis |
| PCT/EP2013/058936 WO2014016003A1 (en) | 2012-07-26 | 2013-04-29 | Use of biotin for the treatment of multiple sclerosis |
| EP13719836.2A EP2729143B1 (en) | 2012-07-26 | 2013-04-29 | Use of biotin for the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20150260T1 true HRP20150260T1 (hr) | 2015-05-08 |
Family
ID=47294963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20150260TT HRP20150260T1 (hr) | 2012-07-26 | 2013-04-29 | Uporaba biotina za lijeäśenje multiple skleroze |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8835487B2 (enExample) |
| EP (2) | EP2729143B1 (enExample) |
| JP (1) | JP6208235B2 (enExample) |
| KR (1) | KR101967502B1 (enExample) |
| CN (2) | CN109908140A (enExample) |
| AU (1) | AU2013295370B2 (enExample) |
| BR (1) | BR112015001562A2 (enExample) |
| CA (1) | CA2879434C (enExample) |
| CY (1) | CY1116304T1 (enExample) |
| DK (2) | DK2729143T3 (enExample) |
| EA (1) | EA030478B1 (enExample) |
| ES (3) | ES2532364T3 (enExample) |
| FR (1) | FR2993780B1 (enExample) |
| HK (1) | HK1207583A1 (enExample) |
| HR (1) | HRP20150260T1 (enExample) |
| HU (1) | HUE024558T2 (enExample) |
| IL (1) | IL236790A (enExample) |
| LT (1) | LT2857019T (enExample) |
| ME (1) | ME02060B (enExample) |
| PL (1) | PL2729143T3 (enExample) |
| PT (2) | PT2729143E (enExample) |
| RS (1) | RS53893B1 (enExample) |
| SI (2) | SI2729143T1 (enExample) |
| SM (1) | SMT201500057B (enExample) |
| WO (1) | WO2014016003A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
| WO2014177286A1 (en) | 2013-04-29 | 2014-11-06 | Assistance Publique - Hopitaux De Paris | Biotin for use in treating x-linked adrenoleukodystrophy |
| JP6108045B2 (ja) * | 2015-02-13 | 2017-04-05 | ユニマテック株式会社 | 含フッ素共重合体およびこれを有効成分とする表面改質剤 |
| EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| WO2017086835A1 (ru) * | 2015-11-17 | 2017-05-26 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты) |
| RU2611415C1 (ru) * | 2015-11-17 | 2017-02-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты) |
| RU2638803C2 (ru) * | 2016-06-09 | 2017-12-15 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Таблетки биотина с замедленным высвобождением и способ их получения |
| EP3275439A1 (en) | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
| AU2017318672B2 (en) * | 2016-09-01 | 2022-03-10 | Nutrition 21, Llc | Magnesium biotinate compositions and methods of use |
| RU2639488C1 (ru) * | 2017-04-06 | 2017-12-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Фармацевтическая композиция, содержащая биотин, и способ ее получения |
| WO2020102203A1 (en) * | 2018-11-13 | 2020-05-22 | Jds Therapeutics, Llc | Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions |
| CN112076310A (zh) * | 2019-06-14 | 2020-12-15 | 苏州融析生物科技有限公司 | 一种治疗多发性硬化的药物组合物及其制备 |
| IL294021A (en) | 2019-12-16 | 2022-08-01 | Nutrition 21 Llc | Methods of production of arginine-silicate complexes |
| CA3157712C (en) | 2020-01-01 | 2024-01-23 | Jotiram PALKAR | Synergistic nutritional compositions for enhancing atp efficiency |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609165A (en) | 1968-07-19 | 1971-09-28 | Research Corp | 1,3-diazabicyclo {8 3.1.0{9 {0 hex-3-enes |
| JPH0995448A (ja) | 1995-09-29 | 1997-04-08 | Calpis Food Ind Co Ltd:The | 血中ビオチン濃度の増加方法およびビオチン含有飲食品 |
| EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
| US5789401A (en) | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
| US6664039B1 (en) | 1998-10-14 | 2003-12-16 | California Institute Of Technology | Methods and compositions for modulating neurodegeneration |
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| DE19903241A1 (de) | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Galenische Formulierung |
| AU2003266287A1 (en) | 2002-08-23 | 2004-03-11 | Dsm Ip Assets B.V. | Novel nutraceutical compositions comprising biotin |
| US7709028B2 (en) | 2002-09-30 | 2010-05-04 | Daiichi Pharmaceutical Co., Ltd. | Particulate product comprising pantethine |
| DE10341240A1 (de) * | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CA2550625C (en) * | 2003-12-31 | 2013-05-28 | Integrative Health Consulting, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
| IL162288A0 (en) * | 2004-06-01 | 2005-11-20 | Future Products Man S A | Compositions and methods for treating neurodegenerative disorders |
| BG66011B1 (bg) * | 2005-05-25 | 2010-10-29 | Райна Щонова | Състав от растителен произход |
| US20130004545A1 (en) | 2009-12-23 | 2013-01-03 | Lupin Limited | Slow release pharmaceutical compositions of iloperidone |
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
-
2012
- 2012-07-26 FR FR1257254A patent/FR2993780B1/fr not_active Expired - Fee Related
- 2012-10-04 US US13/644,615 patent/US8835487B2/en active Active
-
2013
- 2013-04-29 ES ES13719836.2T patent/ES2532364T3/es active Active
- 2013-04-29 PT PT13719836T patent/PT2729143E/pt unknown
- 2013-04-29 EA EA201590270A patent/EA030478B1/ru not_active IP Right Cessation
- 2013-04-29 RS RS20150168A patent/RS53893B1/sr unknown
- 2013-04-29 SI SI201330023T patent/SI2729143T1/sl unknown
- 2013-04-29 CA CA2879434A patent/CA2879434C/en not_active Expired - Fee Related
- 2013-04-29 DK DK13719836.2T patent/DK2729143T3/en active
- 2013-04-29 LT LTEP14194213.6T patent/LT2857019T/lt unknown
- 2013-04-29 AU AU2013295370A patent/AU2013295370B2/en not_active Ceased
- 2013-04-29 HU HUE13719836A patent/HUE024558T2/hu unknown
- 2013-04-29 CN CN201910026016.2A patent/CN109908140A/zh active Pending
- 2013-04-29 ES ES14194213T patent/ES2811074T3/es active Active
- 2013-04-29 HR HRP20150260TT patent/HRP20150260T1/hr unknown
- 2013-04-29 EP EP13719836.2A patent/EP2729143B1/en active Active
- 2013-04-29 WO PCT/EP2013/058936 patent/WO2014016003A1/en not_active Ceased
- 2013-04-29 BR BR112015001562A patent/BR112015001562A2/pt not_active Application Discontinuation
- 2013-04-29 SI SI201331768T patent/SI2857019T1/sl unknown
- 2013-04-29 ME MEP-2015-32A patent/ME02060B/me unknown
- 2013-04-29 PT PT141942136T patent/PT2857019T/pt unknown
- 2013-04-29 KR KR1020157004516A patent/KR101967502B1/ko not_active Expired - Fee Related
- 2013-04-29 PL PL13719836T patent/PL2729143T3/pl unknown
- 2013-04-29 EP EP14194213.6A patent/EP2857019B1/en active Active
- 2013-04-29 DK DK14194213.6T patent/DK2857019T3/da active
- 2013-04-29 HK HK15108330.5A patent/HK1207583A1/xx unknown
- 2013-04-29 CN CN201380039687.3A patent/CN104602689A/zh active Pending
- 2013-04-29 JP JP2015523453A patent/JP6208235B2/ja not_active Expired - Fee Related
-
2014
- 2014-01-14 ES ES14700423.8T patent/ES2626079T3/es active Active
- 2014-08-13 US US14/458,625 patent/US9351961B2/en not_active Expired - Fee Related
-
2015
- 2015-01-19 IL IL236790A patent/IL236790A/en active IP Right Grant
- 2015-03-09 SM SM201500057T patent/SMT201500057B/xx unknown
- 2015-03-11 CY CY20151100243T patent/CY1116304T1/el unknown
-
2016
- 2016-04-12 US US15/096,957 patent/US10201528B2/en not_active Expired - Fee Related
-
2018
- 2018-12-21 US US16/231,073 patent/US20190117625A1/en not_active Abandoned
- 2018-12-21 US US16/231,111 patent/US20190117626A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150260T1 (hr) | Uporaba biotina za lijeäśenje multiple skleroze | |
| JP2015522630A5 (enExample) | ||
| HRP20200600T1 (hr) | Tapentadol za sprječavanje i liječenje depresije i tjeskobe | |
| JP2015038135A5 (enExample) | ||
| NZ599031A (en) | A dosage form containing two or more active pharmaceutical ingredients in different physical forms | |
| WO2017171535A3 (en) | Compositions | |
| WO2007103557A3 (en) | Coating capsules with active pharmaceutical ingredients | |
| FI3435996T3 (fi) | Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa | |
| FI3936130T3 (fi) | Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon | |
| MX370905B (es) | Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos. | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2013231087A5 (enExample) | ||
| TN2011000307A1 (en) | Galenic formulation of organic compounds | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| AU2012284627A8 (en) | Method for manufacturing a pharmaceutical composition in the form of extended-release tablets containing Pirfenidone and use thereof in the regression of chronic renal insufficiency, breast capsular contracture and hepatic fibrosis in humans | |
| UA116334C2 (uk) | Тверді форми дозування бендамустину | |
| HRP20201316T1 (hr) | Novi modulatori receptora sfingozin-fosfata | |
| ME02474B (me) | Terapijski režimi | |
| JP2015508082A5 (enExample) | ||
| PH12014501408A1 (en) | Immediate release multi unit pellet system | |
| HRP20240121T1 (hr) | Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine | |
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| EP2493312A4 (en) | Solid pharmaceutical compositions containing an integrase inhibitor | |
| WO2015087258A8 (en) | Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders | |
| MX2010007281A (es) | Composiciones farmaceuticas de amlodipina y valsartan. |